Carlos de Pommes is an accomplished professional with extensive experience in leadership and strategic roles. He has been the CEO of Remediiate since June 2019 and serves as Managing Director at Algaceuticals since March 2017. Additionally, he has been a Managing Partner at Cambiio since January 2009 and held a Non-Executive Director position at Avespa until June 2019. His earlier experience includes engagement management at McKinsey & Company and managerial roles at Capgemini. Carlos holds an MBA in Strategy, Innovation, and Information Technology from EDHEC Business School and an Honours degree in Aeronautical Engineering from Imperial College London.
